Norbert Maurer
Biochemistry
Transferra Nanosciences
Canada
Biography
Dr. Maurer is a formulation scientist with an accomplished record of advancing many drug technologies from research discovery through preclinical development and into Phase III clinical trials and regulatory approval during the past 20 years. For example liposome-encapsulated docetaxel Alocrest™/vinorelbine to Phase II trials and Marqibo™ that received regulatory approval in 2012.
Research Interest
Biochemistry
